根据《中华人民共和国公司法》（以下简称"《公司法》"）和《公司章程》的规定， 经江苏中旗科技股份有限公司（以下简称"公司"）第四届董事会第五次会议审议通过， 决定于 2025 年 4 月 29 日召开公司 2024 年度股东大会。现将会议相关事项通知如下： 一、召开会议的基本情况 1、 股东大会届次：2024 年度股东大会 证券代码：300575 证券简称：中旗股份 公告编号：2025-012 江苏中旗科技股份有限公司 关于召开 2024 年度股东大会通知的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 （2）网络投票：本次股东大会通过深圳证券交易系统和互联网投票系统向全体股东 提供网络形式的投票平台，股权登记日登记在册的公司股东可以在网络投票时间内通过 上述系统行使表决权。 6、会议的股权登记日：2025 年 4 月 24 日（星期四） 2、 召集人：董事会 3、会议召开的合法、合规性：本次股东大会的召开符合《公司法》、《深圳证券交易 所创业板股票上市规则》等有关法律、行政法规、部门规章、规范性文件及《公司章程》 的规定。 4、会议召开的日期和时间 ( ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-004 本议案尚需提交 2024 年度股东大会审议。 2、审议通过《关于 2024 年度利润分配预案的议案》 江苏中旗科技股份有限公司 第四届监事会第四次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 江苏中旗科技股份有限公司（以下简称"公司"）第四届监事会第四次会议于 2025 年 3 月 28 日在南京市玄武区徐庄软件园苏园路 6 号 2 栋会议室召开，以现场及通讯表 决相结合的方式召开，会议应出席监事 3 人，实际出席监事 3 人（监事孙叔宝以通讯 方式参会）。会议由监事会主席侯远昌先生主持。会议通知已于 2025 年 3 月 13 日以电 话通知等方式向全体监事及高级管理人员送达。本次监事会会议的召开符合《中华人 民共和国公司法》和《公司章程》的有关规定，会议合法、有效。 二、监事会会议审议情况 1、审议通过《关于 2024 年度监事会工作报告的议案》 2024 年，公司监事会严格按照《公司法》《证券法》等法律法规和《公司章程》 的相关规定，切实履行股 ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-003 一、董事会会议召开情况 江苏中旗科技股份有限公司（以下简称"公司"）第四届董事会第五次会议于 2025 年 3 月 28 日在南京市玄武区徐庄软件园苏园路 6 号 2 栋会议室召开，以现场及通讯表 决相结合的方式召开，会议应出席董事 5 人，实际出席董事 5 人。会议由董事长吴耀军 先生主持，公司监事和高级管理人员列席会议。会议通知已于 2025 年 3 月 18 日以电话 通知及电子邮件的方式向全体董事、监事及高级管理人员送达。本次董事会会议的召开 符合《中华人民共和国公司法》（以下简称"《公司法》"）和《江苏中旗科技股份有限 公司章程》（以下简称"《公司章程》"）的有关规定，会议合法、有效。 二、董事会会议审议情况 1、审议通过《关于 2024 年度董事会工作报告的议案》 2024 年，公司董事会严格按照《公司法》《中华人民共和国证券法》等法律法规和 《公司章程》的相关规定，切实履行股东大会赋予的董事会职责，勤勉尽责地开展各项 工作，促进公司持续、健康、稳定的发展。公司独立董事郭卫和周美林均递交了《2024 年度独立董事述职报告》，并 ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-005 江苏中旗科技股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 江苏中旗科技股份有限公司（以下简称"公司或中旗股份"）第四届董事会第五次 会议已于 2025 年 3 月 28 日召开，会议审议通过了《关于 2024 年度利润分配预案的 议案》。现将有关情况公告如下： 一、2024 年年度财务概况 经容诚会计师事务所（特殊普通合伙）出具的容诚审字[2025]230Z0005 号审计报 告，江苏中旗科技股份有限公司 2024 年度实现净利润 10,839,084.06 元，归属于母公 司所有者的净利润为 11,721,037.33 元， 根据《中华人民共和国公司法》和《公司章 程》规定计提法定公积金 2,012,266.67 元，加计以前年度归属于母公司的未分配利润 1,321,436,126.48 元，并扣减 2023 年度利润分配 55,770,768.00 元，合并口径本年度可 供股东分配的利润为 1,275,374,129.14 元。 ...

数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 8802.52万股，累计占流通股比： 25.68%，较上期变化： -2664.61万股。 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0300 | 0.4100 | -92.68 | 0.9000 | | 每股净资产（元） | 0 | 4.66 | -100 | 6.6 | | 每股公积金(元) | 0.43 | 0.43 | 0 | 1.15 | | 每股未分配利润(元) | 2.74 | 2.84 | -3.52 | 4.04 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 24.22 | 23.9 | 1.34 | 29.7 | | 净利润(亿元) | 0.12 | 1.92 | -93.75 | 4.2 | | 净资产收益率(%) | 0.55 | 9.24 | -94.05 | ...

Financial Performance - The company's operating revenue for 2024 was CNY 2,422,198,069.32, representing a 1.35% increase compared to CNY 2,390,013,260.50 in 2023[18]. - The net profit attributable to shareholders for 2024 decreased by 93.88% to CNY 11,721,037.33 from CNY 191,623,058.34 in 2023[18]. - The net profit after deducting non-recurring gains and losses was CNY 24,498,601.05, down 89.02% from CNY 223,181,836.25 in the previous year[18]. - The net cash flow from operating activities was CNY 235,122,998.39, a decline of 41.70% compared to CNY 403,311,873.11 in 2023[18]. - Basic earnings per share fell by 92.68% to CNY 0.03 from CNY 0.41 in 2023[18]. - Total assets increased by 14.41% to CNY 4,412,257,969.81 at the end of 2024, up from CNY 3,856,490,960.65 at the end of 2023[18]. - The net assets attributable to shareholders decreased by 1.97% to CNY 2,122,194,536.87 from CNY 2,164,765,245.63 in 2023[18]. Market and Industry Trends - The pesticide industry is facing pressure due to global economic uncertainties, with prices continuing to decline, leading to a 7.75% drop in the pesticide price index from 86.87 to 80.14 in 2024[31]. - The global pesticide market was valued at $119.2 billion in 2023 and is projected to reach $181.6 billion by 2030, with the herbicide segment expected to grow at a CAGR of 7%[28]. - The company is positioned in a growth phase within the pesticide industry, which is characterized by cyclical trends influenced by the upstream petrochemical sector[33]. - The pesticide market is expected to stabilize as overseas orders recover and domestic sales improve, indicating a potential rebound in prices[31]. Research and Development - The company is focusing on high-quality innovation, with 8 out of 15 newly approved pesticide varieties in 2024 being developed in China[32]. - The company has designed, synthesized, and screened over 20,000 new compounds, discovering dozens of new pesticide candidates, with several innovative products in the pipeline[34]. - The company has a research and development pipeline with several innovative products that have significant market potential, which will be progressively registered and commercialized[49]. - The company has established a first-class R&D team and a safety laboratory, enhancing its capabilities in pesticide innovation and production safety[34]. Production and Capacity - The company has achieved a production capacity of 17,850 tons/year for active ingredients and 4,280 tons/year for formulations, with utilization rates of 74.34% and 84.38% respectively[39]. - The company has ongoing projects for expanding production capacity, including a project for an annual output of 2,000 tons of pesticides and 1,000 tons of potassium chloride[40]. - The total sales volume in the pesticide industry for 2024 was 15,954.61 tons, up 17.98% from 2023[65]. - The production volume for 2024 was 16,880.48 tons, an increase of 18.17% compared to 14,285.24 tons in 2023[66]. Environmental Compliance - The company strictly adheres to various environmental protection laws and regulations, ensuring compliance in its production processes[154]. - The total discharge of COD was reported at 172.975 tons, with no exceedances of discharge standards[156]. - The company has implemented measures to control VOC emissions, with a total discharge of 3.36 tons[156]. - The company is committed to continuous compliance with new environmental regulations and standards[154]. Corporate Governance - The company maintains independence in assets, personnel, finance, organization, and business from the controlling shareholder[111]. - The company has established an independent financial accounting system and does not share bank accounts with the controlling shareholder[112]. - The company is focused on maintaining strong corporate governance practices, as evidenced by the election of independent directors and the establishment of a supervisory board[116]. - The company emphasizes the importance of considering the interests of minority shareholders in decision-making processes[131]. Employee Development - The total number of employees at the end of the reporting period is 2,357, with 1,024 in the parent company and 1,333 in major subsidiaries[137]. - The company has established a comprehensive training system with an annual training plan, offering various training resources for employee development[139]. - The company emphasizes high-level welfare benefits to attract and retain talent, especially technical personnel[138]. - The company implements a performance-based compensation system to encourage employees to enhance their professional capabilities and work performance[138]. Financial Management - The company has maintained effective internal controls with no significant deficiencies reported in financial reporting[147]. - The internal control evaluation report indicates that all major aspects of internal control have been effectively maintained[147]. - The company has engaged independent directors to ensure compliance and transparency in the profit distribution process[142]. - The company is committed to providing stable and reasonable returns to investors while ensuring long-term operational needs are met[145]. Strategic Initiatives - The company plans to invest in new pesticide projects at its production bases in Huai'an, Nanjing, and Ningyitai, while also increasing investment in R&D facilities and projects[101]. - The company aims to expand its product line and enhance its innovation capabilities to meet market demands[100]. - The company will continue to develop both domestic and international markets to drive growth[100]. - The company is exploring strategic partnerships for product distribution to enhance market reach and customer engagement[44].

3月28日，中旗股份今日收盘6.16元，下跌4.64%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到188.24倍，总市值28.63亿元。 从行业市盈率排名来看，公司所处的农药兽药行业市盈率平均46.84倍，行业中值33.12倍，中旗股份排 名第44位。 截至2024年三季报，共有7家机构持仓中旗股份，其中基金7家，合计持股数1536.75万股，持股市值0.93 亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)44中旗股份188.2414.941.3428.63亿行业平均 46.8438.122.5758.31亿行业中值33.1231.131.7141.71亿1苏利股份-357.21135.721.1527.25亿2回盛生 物-90.57246.963.1441.44亿3申联生物-52.58-52.581.6423.94亿4长青股份-34.2145.930.7633.58亿5国发股 份-32.78-34.843.3828.67亿6雅本化学-31.00-81.242.9666.85亿7丰山集团-23.48-50.931.3619.95亿8先达股 份-22.51-23.501.142 ...

中旗股份收盘上涨2.23%，滚动市盈率195.88倍，总 市值29.79亿元 3月26日，中旗股份今日收盘6.41元，上涨2.23%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到195.88倍，创62天以来新低，总市值29.79亿元。 从行业市盈率排名来看，公司所处的农药兽药行业市盈率平均48.01倍，行业中值34.12倍，中旗股份排 名第44位。 资金流向方面，3月26日，中旗股份主力资金净流入252.62万元，近5日总体呈流出状态，5日共流出 364.52万元。 来源：金融界 江苏中旗科技股份有限公司主营业务为农药产品的研发、生产和销售，产品种类主要为除草剂和杀虫剂 原药、制剂及中间体等。除草剂主要包括氯氟吡氧乙酸、精噁唑禾草灵、磺草酮、炔草酯、异噁唑草酮 等，杀虫剂主要包括噻虫胺、虱螨脲等。目前，公司已成为跨国农药公司科迪华（陶氏杜邦农化）、拜 耳、先正达、巴斯夫农化的战略供应商。荣获由中国石油和化学工业联合会颁发的2022年中国石油和化 工500强企业、2020年中国石油化工农药制造业百强企业、2018-2021年中国石油和化工技术创新示范企 业、中国农药工业协会颁发的2023中国农药 ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-002 江苏中旗科技股份有限公司 关于副总经理兼财务总监离职的公告 特此公告。 江苏中旗科技股份有限公司 董事会 2025 年 3 月 1 日 江苏中旗科技股份有限公司（以下简称"公司"）董事会于近日收到公司副总经 理兼财务总监罗航女士的书面离职报告，罗航女士因其劳动合同到期决定不再续签， 不再继续担任公司任何职务或履行相关工作职责。 截至本公告披露日，罗航女士未持有公司股份。罗航女士的原定任期为公司第 四届董事会第二次会议审议通过之日至公司第四届董事会任期届满之日止，其在任 职期间不存在未履行承诺的情况。 根据《中华人民共和国公司法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等相关 法律、法规及《公司章程》的规定，罗航女士的离职报告自送达公司董事会之日起 生效，其离职不会对公司日常生产经营和管理产生不利影响。公司将按照相关规定 尽快聘任新的财务总监。为保证公司财务工作正常开展，在董事会聘任新的财务总 监之前，由公司董事长兼总经理吴耀军先生代行财务总监职责。 罗航女士担任公司副 ...

Profit Projections - The estimated net profit attributable to shareholders for 2024 is projected to be between 10 million and 15 million yuan, representing a decline of 92.17% to 94.78% compared to the previous year's profit of 191.62 million yuan[3]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 20.5 million and 30 million yuan, reflecting a decrease of 86.56% to 90.81% from the previous year's profit of 223.18 million yuan[3]. Non-Recurring Gains and Losses - The impact of non-recurring gains and losses on net profit is estimated to be between 5.5 million and 20 million yuan during the reporting period[6]. Market Conditions - The decline in overall profit is attributed to slow recovery in customer demand, market oversupply, and continuous low prices in the agricultural chemical product market, leading to decreased order prices and gross margins[5].